Saturday, September 20, 2025 12:01:43 AM
You could be right, but even then I don't know that somebody only wishing to purchase DCVax-L without Keytruda, etc, shouldn't be able to get it regardless of who they're buying it from.
If all vaccine is to be provided by Advent, without the spokes, and if they gain International approval, they'll need far more capacity than they're building. If they achieve a tumor agnostic label, the requirements will be massive.
I really like the hub and spoke model. A larger spoke, like City of Hope, might very well be able to handle tens of EDEN units in just what I've seen, and I doubt if that's 1% of the capacity there. I really don't know, but I know they have a number of research buildings there that I never got near, but was amazes at what's underground, which I saw when transported between buildings in an underground corridor surrounded by labs.
I believe that research institutions and hospitals that have the cleanrooms and cryogenic capabilities also have all the other capabilities needed so that everything needed for a patient having the surgery there can be done there.
Certainly a patient wouldn't be held at the hospital until the vaccine was completed, they might go home the day of the surgery. They would either come back to get it, or perhaps it would be sent to their oncologist's office to be administered.
Gary
If all vaccine is to be provided by Advent, without the spokes, and if they gain International approval, they'll need far more capacity than they're building. If they achieve a tumor agnostic label, the requirements will be massive.
I really like the hub and spoke model. A larger spoke, like City of Hope, might very well be able to handle tens of EDEN units in just what I've seen, and I doubt if that's 1% of the capacity there. I really don't know, but I know they have a number of research buildings there that I never got near, but was amazes at what's underground, which I saw when transported between buildings in an underground corridor surrounded by labs.
I believe that research institutions and hospitals that have the cleanrooms and cryogenic capabilities also have all the other capabilities needed so that everything needed for a patient having the surgery there can be done there.
Certainly a patient wouldn't be held at the hospital until the vaccine was completed, they might go home the day of the surgery. They would either come back to get it, or perhaps it would be sent to their oncologist's office to be administered.
Gary
Bullish
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
